Fig. 5From: Efficacy of capecitabine and oxaliplatin versus S-1 as adjuvant chemotherapy in gastric cancer after D2 lymph node dissection according to lymph node ratio and N stageOS and DFS of XELOX and S-1 in LNR3. XELOX regimen showed significantly better efficacy compared to S-1 in LNR3 patients in terms of OS and DFSBack to article page